Who Benefits From Federal Cannabis Limbo? ft. Jay Rosenthal

I think credit cards and capital markets, you know, New York Stock Exchange, NASDAQ, I think that would be helpful to many.

Although, you know, the path to the New York Stock Exchange, it's good to be first or second.

It has not led to some massive influx of capital for the companies that are listed there.

So, you know.

It would be good.

It would be nice.

But that's actually not happening in D.C. That's happening in New York.

And even if something happens in D.C., the New York Stock Exchange and NASDAQ may have something to say about who gets listed.

The reason I wonder if they're not getting like as much action, Boris talked about how like BlackRock, when it was at the Benzinga Capital Conference, which is now the Ignite, sorry guys, about using the old name.

He mentioned the size of the business is what needs to be bigger in order to attract some of those elements.

I wonder if that is currently a holdup in the process and teams think about, hey, how do we become more attractive to some of these larger players?

Yeah, I was actually talking to someone, I think I mentioned a baseball dad, who was talking about the companies listed here in Canada.

He's done some work for them, the ones that were on the TSX and the CSE.

The CSE, Canadian Securities Exchange, which is actually a partner of Cultivated, was the first place that got publicly listed cannabis companies.

And just the requirements for the CSE, the capital requirements, the regulatory requirements, the filing requirements are less on the CSE than they are in the TSX, are less in the TSX than they are in New York.

And so in some respects, while they would love the access to the capital that New York brings, they probably also appreciate that they can be smaller with less regulatory burden, less filing in Canada for now.

Yeah, pros and cons with each.

And then as regulatory changes, let's say evolves.

Yeah.

Then I think where it gets really interesting is these big fish in a small pond become small fish in a bigger pond.

And now we get these bigger players coming in.

And there's already some tobacco players, right? We see DAT already in here with Organigram and how they publicly position themselves or privately, however you want to describe it.

But there's no doubt about it.

These companies are operating way today and You know, one can hope that the bigger companies right in the outside space are thinking, hey, let these cannabis companies kill each other off, figure out who the strongest are and we'll come in and those will be our partners because those larger companies, we're blunt on their rate, are not even worth their time.

And you think about some of those more established industries, they have a much longer lens, right? They're not struggling to survive right now.